Authors

• Rudi Chandra (ORCID: https://orcid.org/0000-0002-7662-1036)
• Cesar Nava Gonzales
• Álvaro González‐Cantero (ORCID: https://orcid.org/0000-0001-8060-4784)
• Benjamín Hidalgo Matlock
• Mona El‐Kalioby (ORCID: https://orcid.org/0000-0002-9208-2458)
• Tiago Torres (ORCID: https://orcid.org/0000-0003-0404-0870)
• Filip Rob (ORCID: https://orcid.org/0000-0001-5257-205X)
• Andrew Blauvelt (ORCID: https://orcid.org/0000-0002-2633-985X)
• Julia‐Tatjana Maul (ORCID: https://orcid.org/0000-0002-9914-1545)
• Bruce E Strober (ORCID: https://orcid.org/0000-0002-8394-2057)
• Lone Skov
• Pravit Asawanonda
• P C van de Kerkhof

Institutions

• University of Copenhagen (DK)
• Cairo University (EG)
• Radboud University Nijmegen (NL)
• Chulalongkorn University (TH)
• Universidade do Porto (PT)
• Charles University (CZ)
• Universidad Francisco de Vitoria (ES)
• Gentofte Hospital (DK)
• Radboud University Medical Center (NL)
• Yale University (US)
• Universitas Prima Indonesia (ID)
• University Hospital of Zurich (CH)
• Maryland Department of Natural Resources (US)
• Hospital de Santo António (PT)
• Hospital Nacional de Niños (CR)
• Centro Hospitalar do Porto (PT)
• Fundación Universitaria Sanitas (CO)

Publication Details

Journal

Journal of the American Academy of Dermatology

Published

2025-06-06

DOI

https://doi.org/10.1016/j.jaad.2025.05.1445

Citations

4

Primary Topic

Health Systems, Economic Evaluations, Quality of Life

Type

article

Field-Weighted Citation Impact

12.52

Funders

• Bristol-Myers Squibb
• National Psoriasis Foundation
• Eli Lilly and Company
• Pfizer
• Sanofi
• Biogen
• Celgene
• Mylan
• Kongelig Hofbuntmager Aage Bangs Fond
• Galderma
• LEO Fondet
• LEO Pharma
• Samsung